Download the free
Parkinson's disease
case study
Sano worked with a pioneering biotech company to identify, screen and retain LRRK2:G2019S genetic Parkinson’s Disease (PD) patients for the initial stages of a new treatment development program.
Global prevalence rates of this genetic variation are 1% in sporadic PD and 4% in familial PD.
Download our case study to learn more.

Download Case Study
Parkinson's disease Case Study
Sano worked with a pioneering biotech company to identify, screen and retain LRRK2:G2019S genetic Parkinson’s Disease (PD) patients for the initial stages of a new treatment development program.
Global prevalence rates of this genetic variation are 1% in sporadic PD and 4% in familial PD.

Key Highlights

2x the industry benchmark hit-rate

55% cost savings using at-home DNA testing service vs. site visit